Vicore Pharma is leveraging in understanding the Renin-Angiotensin System (RAS) to develop angiotensin II type 2 receptor agonists for IPF and beyond
Nov 11, 2025
06:49
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
CEO Ahmed Mousa walks us through the sciences and describes how data stacked up against a synthetic external control that was presented at a medical meeting this summer.